Intellectual Property News & Topics - Secerna LLP

REXULTI

A to Z: Drugs in Highlight: R is for REXULTI®

News A to Z Feature 03/04/2025

This series continues to explore the fascinating world of pharmaceuticals. Next up is R is for REXULTI® (from Otsuka Pharmaceutical), also sold under the brand name RXULTI®, It is an antipsychotic medicine used to treat schizophrenia in adults. It is also used as an adjunctive therapy for the treatment of major depressive disorder.

Read more

Secerna Website Images 2023 (16)

European, News 23/10/2023

Protecting Smart Health Wearable Innovations with Intellectual Property

IP Career

News 16/10/2023

A Rewarding Career at the Forefront of Innovation

Secerna Website Images 2023 (10)

News 13/10/2023

Secerna to exhibit at Newcastle University's Graduate Recruitment and Placements Fair

EPO

European, News 29/09/2023

Urgent Reminder: Abolition of the EPO's "10-Day Rule" on November 1st 2023

Secerna Website Images 2023 (8)

European, News 27/09/2023

EU Intellectual Property Legislation for Industrial Designs to be Modernised

European, News 13/09/2023

Protecting AI-Enhanced Medical Technologies in Europe

Secerna Website Images 2023 (5)

European, Industry news, News 08/09/2023

UK Rejoins EU's Horizon Europe Scientific Research Programme

Huw And Niamh

Events, News 08/09/2023

Secerna to attend BioYorkshire: Activating the bioeconomy

Jason And Matthew Secerna Website Images 2023

News, Team news 07/09/2023

Secerna's Growth Continues with the Arrival of a New Trainee Patent Attorney

11 12 13 14 15 16 17 18 19 20 21